University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program

德克萨斯大学西南分校 - 促进住院医师研究 (UT-StARR) 计划

基本信息

  • 批准号:
    10318221
  • 负责人:
  • 金额:
    $ 33.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Abstract Despite decades of research in the understanding and treatment of diseases of the heart and lung, cardiovascular and pulmonary diseases remain the leading causes of hospitalization, disability, and death in the U.S. Notably, growing numbers of patients with childhood-onset chronic illnesses, such as congenital heart defects, cystic fibrosis, bronchopulmonary dysplasia, and hemophilia, are surviving into adulthood, making it imperative to conduct research encompassing the lifespan. Against this background of critical research needs, there is a strikingly growing shortage of M.D.-scientists, such that the proportion of M.D.s that remain primarily in research careers has decreased by 3-fold in the last 3 decades, despite the climbing number of total physicians in practice. The pipeline of M.D.-scientist development is also at risk: fewer medical students express interest in a research career, and fewer graduates apply for NIH funding. Importantly, relative to the overall physician workforce, women and minorities are disproportionately underrepresented in the proportion of M.D.-scientists. These challenges require the implementation of innovative recruitment and training strategies to feed the M.D.- scientist pipeline and ensure that women and minorities are well-represented. To help fill these critical gaps, we will establish the University of Texas Southwestern (UTSW) - Stimulating Access to Research in Residency (UT-StARR) training program to recruit and train a diverse group of Internal Medicine and Pediatrics residents that will become the next generation of M.D.-scientists conducting laboratory-based, translational, clinical, and population health research to detect, treat, and prognosticate diseases affecting the heart, lungs, and blood of diverse populations throughout the lifespan. Our institution will provide an ideal environment with a multidisciplinary cadre of funded research; robust didactic training program; and diverse patient population. We hypothesize that the 3 axes of diversity at UTSW - M.D. trainees, mentors, and patient community - afford the unique opportunity to address unmet needs in M.D. research training, personalized medicine, and population health. The following Aims organize our approach: Aim 1. To provide broad-based comprehensive mentored research training for a group of diverse Internal Medicine and Pediatric resident-investigators in the conception, design, and implementation of laboratory-based, translational, clinical, and population research in diseases affecting the heart, lungs and blood, encompassing detection, prevention, treatment, and outcomes to improve the health of individuals and populations throughout the human lifespan; Aim 2. To provide the essential research training and mentoring platform needed to build a strong foundation allowing successful transition of residents to independent M.D.-scientists conducting biomedical research in the heart, lung, and blood fields; Aim 3. To enhance the participation and persistence of M.D.s from underrepresented groups in research by implementation and maintenance of institutional mentored residency training programs involving diverse residents, mentors, and patients through evaluation and monitoring the progress of UT-StARR and other institutional training programs.
项目摘要 尽管在理解和治疗心脏和肺部疾病方面进行了数十年的研究, 心血管疾病和肺部疾病仍然是老年人住院、残疾和死亡的主要原因。 美国值得注意的是,越来越多的儿童期慢性疾病患者,如先天性心脏病, 缺陷,囊性纤维化,支气管肺发育不良,血友病,存活到成年,使它 必须进行涵盖生命周期的研究。在这一关键研究需求的背景下, 医学博士的短缺正在急剧增加科学家,这样的比例,医学博士,仍然主要是 在过去的30年里,尽管医生总数不断攀升, 在实践中医学博士的管道-科学家的发展也处于危险之中:很少有医学生对 研究生涯,更少的毕业生申请国家卫生研究院的资金。重要的是,相对于整体医生, 劳动力、妇女和少数民族在医学博士中的比例不成比例地偏低。科学家 这些挑战需要实施创新的招聘和培训战略,以满足医学博士的需求。 科学家管道,并确保妇女和少数民族的代表性。为了帮助填补这些关键空白,我们 将建立得克萨斯州西南大学(UTSW)-刺激获得研究, 住院医师(UT-StARR)培训计划,招募和培训内科和儿科的多元化群体 他们将成为下一代医学博士科学家们进行基于实验室的,转化的, 临床和人口健康研究,以检测,治疗和预测影响心脏,肺, 在整个生命周期中,不同人群的血液。我们的机构将提供一个理想的环境, 多学科骨干资助的研究;强大的教学培训计划;和多样化的患者人群。我们 假设UTSW -MD的三个多样性轴学员,导师和患者社区-提供 独特的机会,以解决医学未满足的需求。研究培训、个性化医疗和人口 健康以下目标组织了我们的方法:目标1。提供基础广泛的综合辅导, 为一组不同的内科和儿科住院研究员提供研究培训, 设计和实施以实验室为基础的、转化的、临床的和人群的疾病研究 影响心脏,肺和血液,包括检测,预防,治疗和结果,以改善 个人和人口在整个人类寿命期间的健康;目标2。提供必要的研究 培训和指导平台需要建立一个坚实的基础,使居民能够成功过渡 独立医学博士在心脏、肺和血液领域进行生物医学研究的科学家;目标3。到 通过实施,加强来自代表性不足群体的医学博士在研究中的参与和坚持 和维护机构指导的住院医师培训计划,涉及不同的居民,导师, 通过评估和监测UT-StARR和其他机构培训计划的进展,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan Hedayati其他文献

Susan Hedayati的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan Hedayati', 18)}}的其他基金

Blood Biomarkers Associated with Adverse Outcomes in Heart Failure
与心力衰竭不良后果相关的血液生物标志物
  • 批准号:
    10650694
  • 财政年份:
    2023
  • 资助金额:
    $ 33.47万
  • 项目类别:
Mechanisms for Behavior Change and Maintenance of Treatment for CKD Comorbid Depression
CKD 共病抑郁症的行为改变和维持治疗机制
  • 批准号:
    10667222
  • 财政年份:
    2022
  • 资助金额:
    $ 33.47万
  • 项目类别:
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
CKD 共病抑郁症的新疗法组合 (CONCORD)
  • 批准号:
    10640205
  • 财政年份:
    2020
  • 资助金额:
    $ 33.47万
  • 项目类别:
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
CKD 共病抑郁症的新疗法组合 (CONCORD)
  • 批准号:
    10404490
  • 财政年份:
    2020
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    8212573
  • 财政年份:
    2011
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    8792383
  • 财政年份:
    2011
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    8607181
  • 财政年份:
    2011
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    8423402
  • 财政年份:
    2011
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    8042121
  • 财政年份:
    2011
  • 资助金额:
    $ 33.47万
  • 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
  • 批准号:
    7787841
  • 财政年份:
    2009
  • 资助金额:
    $ 33.47万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 33.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了